In this study, we showed that NPC2 downregulation-mediated free cholesterol accumulation attenuated sorafenib-induced cytotoxicity through enhancing MAPK and AKT signaling in HCC cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.